NCT00482417View on ClinicalTrials.gov

Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

PHASE2CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions

Rheumatoid Arthritis

Interventions

DRUG

MK0359

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482417 - Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) | Biotech Hunter | Biotech Hunter